Charcot-Marie-Tooth disease Clinical Trials

15 recruitingLast updated: June 20, 2026

There are 15 actively recruiting charcot-marie-tooth disease clinical trials across 9 countries. Studies span Not Applicable, Phase 1, Phase 2. Top locations include Boston, Massachusetts, United States, Hartford, Connecticut, United States, Aurora, Colorado, United States. Updated daily from ClinicalTrials.gov.


Charcot-Marie-Tooth disease Trials at a Glance

15 actively recruiting trials for charcot-marie-tooth disease are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Boston, Hartford, and Aurora. Lead sponsors running charcot-marie-tooth disease studies include ENCell, Hereditary Neuropathy Foundation, and Assistance Publique Hopitaux De Marseille.

Browse charcot-marie-tooth disease trials by phase

Treatments under study

About Charcot-Marie-Tooth disease Clinical Trials

Looking for clinical trials for Charcot-Marie-Tooth disease? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Charcot-Marie-Tooth disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Charcot-Marie-Tooth disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 115 of 15 trials

Recruiting
Phase 1Phase 2

Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A(CMT1A) (Phase 1b: Open-label, Dose-escalation, Single-center; Phase 2a: Randomized, Double-blind, Placebo-controlled, Multicenter)

Charcot-Marie-Tooth Disease, Type 1A
ENCell27 enrolled3 locationsNCT06328712
Recruiting

TREMOR IN CHARCOT-MARIE-TOOTH

Charcot Marie Tooth Disease (CMT)CMTCharcot-Marie-Tooth disease+1 more
University Medical Center Goettingen75 enrolled1 locationNCT07570459
Recruiting
Phase 1

A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of EDK060 in Adults With CMT1A.

Charcot-Marie-Tooth Disease, Type 1A
Novartis Pharmaceuticals28 enrolled3 locationsNCT07140614
Recruiting

Observational Study to Observe Variations of Gait Parameters in Patients With Neuromuscular Diseases

Muscular DystrophiesCharcot-Marie-Tooth diseaseSpinal Muscular Atrophy (SMA)+1 more
IRCCS Eugenio Medea120 enrolled2 locationsNCT06666816
Recruiting

Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2

Charcot-Marie-Tooth Disease, Type Ia (Disorder)HMSN
University of Iowa1,050 enrolled22 locationsNCT01193088
Recruiting

Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others

Charcot-Marie-Tooth disease
Michael Shy5,000 enrolled22 locationsNCT01193075
Recruiting

A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders

Metabolic DiseaseAMPD3, OMIM*102772, AMP Deaminase DeficiencyAK1, OMIM *103000, Adenylate Kinase Deficiency+25 more
National Human Genome Research Institute (NHGRI)999 enrolled1 locationNCT06092346
Recruiting

Genotype/Phenotype Correlation of MORC2 Mutations

Impaired growthCharcot-Marie-Tooth diseaseDevelopmental Delay Disorder+2 more
Hospices Civils de Lyon45 enrolled12 locationsNCT07038239
Recruiting
Not Applicable

Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease

Charcot-Marie-Tooth Disease, Type 1A
Assistance Publique Hopitaux De Marseille55 enrolled1 locationNCT07049588
Recruiting
Not Applicable

High-Tech Rehabilitation Pathway for Chronic Adult Neuromuscular Diseases - Fit4MedRob-Chronic MND Project

Amyotrophic Lateral SclerosisCharcot-Marie-Tooth diseaseChronic Inflammatory Demyelinating Neuropathy
Istituti Clinici Scientifici Maugeri SpA60 enrolled7 locationsNCT06881979
Recruiting

Charcot-Marie-Tooth Disease (CMT) Biological Sample Collection for IPSC Generation and Biobanking

HealthyCharcot-Marie-Tooth disease
New York Stem Cell Foundation Research Institute50 enrolled1 locationNCT06203093
Recruiting

Natural History Study for Charcot Marie Tooth Disease

Charcot-Marie-ToothCharcot-Marie-Tooth diseaseCharcot-Marie-Tooth Disease, Type IA+45 more
Hereditary Neuropathy Foundation10,000 enrolled1 locationNCT05902351
Recruiting

A Registered Cohort Study on Charcot-Marie-Tooth Disease

Charcot-Marie-Tooth disease
Ning Wang, MD., PhD.500 enrolled1 locationNCT04010188
Recruiting
Phase 2

A randomised phase II study to evaluate the effectiveness of botulinum toxin to delay, and possibly prevent, progressive foot deformities in children with Charcot-Marie-Tooth (CMT) disease.

Charcot-Marie-Tooth disease
The Children's Hospital at Westmead10 enrolled1 locationACTRN12605000115639
Recruiting

Night casting and stretching to improve function in people with Charcot-Marie-Tooth disease

Charcot-Marie-Tooth disease
University of Sydney30 enrolled1 locationACTRN12605000011684